GSK3B and juvenile Huntington disease: In addition, BER has been shown to protect against cognitive impairment by stimulating PKC/ ERK /CREB, further increasing the expression of BDNF and inhibiting the downstream PKC effector GSK3β in quinolinic acid-injected mice (mouse model of Huntington’s disease)(65).